Patent details

EP1467724 Title: ORODISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING AGOMELATINE

Basic Information

Publication number:
EP1467724
PCT Application Number:
PCT/FR/2003/000197
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037317336
PCT Publication Number:
WO/2003/061644
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
ORODISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING AGOMELATINE
French Title of Invention:
COMPOSITION PHARMACEUTIQUE ORODISPERSIBLE D'AGOMELATINE
German Title of Invention:
IN DER MUNDHÖHLE DISPERGIERBARE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT AGOMELATIN
SPC Number:

Dates

Filing date:
22/01/2003
Grant date:
03/05/2006
EP Publication Date:
03/05/2006
PCT Publication Date:
31/07/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/10/2004
EP B1 Publication Date:
03/05/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/01/2019
Expiration date:
22/01/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/01/2003
 
 

Name:
Les Laboratoires Servier
Address:
12, place de la Défense, 92415 Courbevoie Cédex, France (FR)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/05/2006
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WUTHRICH Patrick
Address:
France (FR)

2

Name:
JULIEN Marc
Address:
France (FR)

3

Name:
THARRAULT François
Address:
France (FR)

4

Name:
ROLLAND Hervé
Address:
France (FR)

Priority

Priority Number:
0200792
Priority Date:
23/01/2002
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 31/165;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
23/11/2017
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
31/05/2019 Outgoing Correspondence 1